Profil bibliographique

Joon Ho Lee

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

70Publications signalées

3800Citations signalées

4Affiliations récentes

Les institutions déclarées

Yonsei University Severance Hospital Gangnam Severance Hospital Celltrion (South Korea)

Les domaines associés

Inflammatory Bowel DiseaseBiosimilars and Bioanalytical MethodsMicroscopic ColitisGastric Cancer Management and OutcomesColorectal Cancer Treatments and Studies

Les publications récentes

Accès ouvert 2025 article OpenAlex

Glycosylated Hemoglobin Levels in the Third Trimester for Predicting Adverse Pregnancy and Neonatal Outcomes in Women with Pre-Gestational Diabetes: A Multi-Center Retrospective Cohort Study in South Korea

Suyeon Park, Mi-Ju Kim, Subeen Hong, Ji‐Hee Sung et autres

kr, jp, us (code pays fourni par la source)

0 citations Journal of Clinical Medicine

Accès ouvert 2025 article OpenAlex

1209P Guideline-practice gap in molecular subtyping and Lynch syndrome screening for endometrial cancer in Korea

J-H Kim, G-H. Tak, Myeong‐Jin Kim, Y-N. Kim et autres

kr (code pays fourni par la source)

0 citations Annals of Oncology

Accès ouvert 2025 article OpenAlex

Subcutaneous infliximab (CT-P13 SC) as maintenance therapy for Crohn’s disease and ulcerative colitis: 2-year results from open-label extensions of two randomized controlled trials (LIBERTY)

Jean–Frédéric Colombel, William J. Sandborn, Silvio Danese, Maria Kłopocka et autres

us, de, it, pl, ua, rs, ru, il, hr, kr (code pays fourni par la source)

7 citations Journal of Crohn s and Colitis

Accès ouvert 2025 article OpenAlex

Comparing Outcomes With Subcutaneous Infliximab (CT-P13 SC) by Baseline Immunosuppressant Use: A Post Hoc Analysis of the LIBERTY-CD and LIBERTY-UC Studies

Stefan Schreiber, Jean‐Frédéric Colombel, Stephen B. Hanauer, William J. Sandborn et autres

de, us, it, kr (code pays fourni par la source)

9 citations Inflammatory Bowel Diseases

Accès ouvert 2024 article OpenAlex

Subcutaneous Infliximab (CT-P13 SC) as Maintenance Therapy for Inflammatory Bowel Disease: Two Randomized Phase 3 Trials (LIBERTY)

Stephen B. Hanauer, Bruce E. Sands, Stefan Schreiber, Silvio Danese et autres

us, de, it, pl, ua, rs, ru, il, hr, kr (code pays fourni par la source)

68 citations Gastroenterology

2024 conference-abstract OpenAlex

Su1779 SUBCUTANEOUS INFLIXIMAB (CT-P13 SC) FOR ULCERATIVE COLITIS: 2-YEAR EXTENSION RESULTS OF THE LIBERTY-UC STUDY

William J. Sandborn, Bruce E. Sands, Stephen B. Hanauer, Jean‐Frédéric Colombel et autres

0 citations Gastroenterology

2024 article OpenAlex

Comparative Evaluation of Inbreeding Parameters in Korean Commercial Pig Breeds Using Genomic and Pedigree Information

Jun Park, Joon Ho Lee

0 citations Journal of Agriculture & Life Science

Accès ouvert 2024 article OpenAlex

SUBCUTANEOUS INFLIXIMAB (CT-P13 SC) DOSE ESCALATION AS AN OPTION FOR MANAGING THE LOSS OF RESPONSE IN INFLAMMATORY BOWEL DISEASE POST HOC ANALYSIS OF LIBERTY-UC AND LIBERTY-CD STUDY

Silvio Danese, Jean–Frédéric Colombel, Stephen B. Hanauer, William J. Sandborn et autres

0 citations Gastroenterology

Accès ouvert 2024 article OpenAlex

EFFICACY, SAFETY AND IMMUNOGENICITY OF SUBCUTANEOUS INFLIXIMAB (CT-P13 SC) MONOTHERAPY VERSUS COMBINATION THERAPY WITH IMMUNOSUPPRESSANTS – POST HOC ANALYSIS OF LIBERTY-CD AND LIBERTY-UC STUDY

Stefan Schreiber, Jean–Frédéric Colombel, Stephen B. Hanauer, William J. Sandborn et autres

0 citations Inflammatory Bowel Diseases

Accès ouvert 2024 conference-abstract OpenAlex

SUBCUTANEOUS INFLIXIMAB (CT-P13 SC) DOSE ESCALATION AS AN OPTION FOR MANAGING THE LOSS OF RESPONSE IN INFLAMMATORY BOWEL DISEASE POST HOC ANALYSIS OF LIBERTY-UC AND LIBERTY-CD STUDY

Silvio Danese, Jean–Frédéric Colombel, Stephen B. Hanauer, William J. Sandborn et autres

0 citations Inflammatory Bowel Diseases

Accès ouvert 2024 article OpenAlex

EFFICACY, SAFETY AND IMMUNOGENICITY OF SUBCUTANEOUS INFLIXIMAB (CT-P13 SC) MONOTHERAPY VERSUS COMBINATION THERAPY WITH IMMUNOSUPPRESSANTS – POST HOC ANALYSIS OF LIBERTY-CD AND LIBERTY-UC STUDY

Stefan Schreiber, Jean–Frédéric Colombel, Stephen B. Hanauer, William J. Sandborn et autres

3 citations Gastroenterology

Accès ouvert 2024 conference-abstract OpenAlex

P902 Subcutaneous infliximab (CT-P13 SC) as maintenance therapy for Crohn’s disease: 2 years results of the LIBERTY-CD study

Jean‐Frédéric Colombel, Stephen B. Hanauer, William J. Sandborn, B E Sands et autres

us, de, it, pl, ua, il, ru, hr, kr (code pays fourni par la source)

2 citations Journal of Crohn s and Colitis

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.